Based on these novel findings, we anticipate that fucoxanthin might provide significant therapeutic efficacy for the treatment of AD by acting on multiple targets, including inhibiting AChE and increasing BDNF expression in particular. The gene discussed is ACHE; the disease is Alzheimer disease.